Safety and Efficacy of Coil Embolization for Endoleak Prevention as an Adjunct to Endovascular Repair of Abdominal Aortic Aneurysm or Subsequently for the Repair of Endoleak
This study demonstrated that the use of Cerenovus coils yielded a high rate of 30-day-reintervention-free survival and low rates of type II endoleak occurrence and recurrence at the target vessel through 30 days and 1 year in patients following EVAR of an AAA with coil embolization, either for prophylactic endoleak prevention during EVAR or as a reintervention to repair an endoleak.
Authors
- Soichiro Hase
- Takashi Otani (ORCID: https://orcid.org/0000-0001-5673-516X)
- Anita Yau
- Toshiaki Yagami (ORCID: https://orcid.org/0009-0007-8912-6572)
- Tassei Nakagawa
- A Honda (ORCID: https://orcid.org/0009-0008-6914-8552)
Institutions
- Johnson & Johnson (United States) (US)
- Saiseikai Utsunomiya hospital (JP)
- Tokushima Red Cross Hospital (JP)
- Kawasaki Hospital (JP)
- Johnson & Johnson (Brazil) (BR)
Publication Details
- Journal
- Annals of Vascular Surgery
- Published
- 2024-11-22
- DOI
- https://doi.org/10.1016/j.avsg.2024.10.027
- Primary Topic
- Aortic aneurysm repair treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00